U.S. BioPharma Expansions to Europe: Build Out & Market Access

Join the virtual roundtable* “U.S. BioPharma Expansions to Europe: Build Out & Market Access” with Apellis, Korn Ferry & the Canton of Zug, Switzerland; hosted by the Greater Zurich Area Ltd.

With a selected group of life sciences executives, the discussion round will focus on best practices and tips on how to successfully expand to Europe from the U.S. and access European markets. While our guest speakers will share their experience and expertise, the event aims to stimulate an open debate on options for US biotech companies that want to build a presence in Europe.

Speakers

• Thomas Lackner, SVP, Head of International, Apellis Pharmaceuticals
• Andrea Bracco, VP International Value, Access & Policy & Ad-interim GM Italy/Greece, Apellis Pharmaceuticals
• Oliver Schiltz, Managing Partner, Korn Ferry Switzerland
• Beat Bachmann, Head Economic Promotion, Canton of Zug
• Moderated by Lukas Sieber – Executive Director North America, Greater Zurich Area Ltd. 

Goals & Objectives

• Discussing Apellis' path in Europe and how to successfully expand
• Pitfalls to avoid when accessing the European market
• Lessons learned building out in Switzerland
• Discussing jurisdictional considerations of an expansion

Format

Exclusive roundtable of 1 hour set up as a virtual panel and Q&A. Short input presentations representing the most relevant perspectives (Apellis’ story, market access, talent, jurisdiction) followed by a moderated Q&A. 10-15 selected guests, invitation-only, Chatham house rules.

*Attendance is by invitation only. Interested in attending? Get in touch.